Blog

FDA approval of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis marks the availability of the only balloon expandable stent graft with an indication for the iliac artery. ...
Medtronic recently announced that it has received CE Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that also allow patients to receive MRI scans in either 1.5 or 3 Tesla (T) machines....
Konica Minolta Healthcare recently announced the launch of its J5 Ultrasound System, a portable system with touch-screen intuitive navigation that produces high quality real-time images of the musculoskeletal (MSK) system....
BioDerm® Inc. recently announced the launch of their new partnership with CellMark Medical to bring the next generation of urinary management, securement and skin protection devices into select Asian markets....
In countries such as Italy, Germany and Spain, there is a plethora of local value and discount dental implant companies that have emerged to cater to the growing cost sensitivity expressed by dentists....
By Payam Moghimi-Bidhendi and Kamran Zamanian, Ph.D, iData Research Inc Introduction The U.S. orthopedic biomaterials market has become an attractive alternative for patients looking to avoid surgical implantation of permanent devices or hardware. Orthopedic surgeries are generally complicated, multi-stage procedures...
Bone graft substitute comprised of viable, lineage committed bone cells delivers all three properties required for bone formation...
Cellular allografts currently comprise the fastest growing segment of the orthopedic biomaterials market in the U.S.; the high average selling price of cellular allografts provides incentives for new players to enter the market....
The market for hemodialysis machines is comprised of in-center machines and home hemodialysis machines; the market will exceed a value of $360 million by 2023....
Integra LifeSciences Holdings Corporation, recently announced that it has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of $1.045 billion....

Thank you!

CLOSE

Login

Sign Up

Already have an account? Sign in

×